Overcoming NOTCH1-Driven Chemoresistance in T-Cell Acute Lymphoblastic Leukemia Via Metabolic Intervention with Oxphos Inhibitor
Natalia Baran(The University of Texas MD Anderson Cancer Center), Marina Konopleva(Albert Einstein College of Medicine), Anna Skwarska(Albert Einstein College of Medicine), Ken Furudate(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Vivian Ruvolo(Hormel (United States)), Shanti Rojas‐Sutterlin(Université de Montréal), Shelley M. Herbrich(The University of Texas MD Anderson Cancer Center), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Stefano Tiziani(Dell Children's Medical Center of Central Texas), Adolfo A. Ferrando(Regeneron (United States)), David T. Teachey(Children's Hospital of Philadelphia), Di Du(The University of Texas MD Anderson Cancer Center), Marc O. Warmoes(The University of Texas MD Anderson Cancer Center), Jared Henderson(The University of Texas MD Anderson Cancer Center), Helen Ma(Columbia University Irving Medical Center), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), Elias Jabbour(The University of Texas MD Anderson Cancer Center), André Haman(Institute for Research in Immunology and Cancer), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Ondřej Havránek(The University of Texas MD Anderson Cancer Center), Jun J. Yang(St. Jude Children's Research Hospital), Mihai Gagea(The University of Texas MD Anderson Cancer Center), Philip L. Lorenzi(City Of Hope National Medical Center), Fieke W. Hoff(University Medical Center Groningen), Yogesh Dhungana(St. Jude Children's Research Hospital), May Daher(The University of Texas MD Anderson Cancer Center), Karine G. Harutyunyan(Baylor College of Medicine), Terzah M. Horton(Unknown), Vinitha M. Kuruvilla(The University of Texas MD Anderson Cancer Center), Shannon Sweeney(The University of Texas at Austin), Diogo F. T. Veiga(Universidade Estadual de Campinas (UNICAMP)), Ningping Feng(The University of Texas MD Anderson Cancer Center), Antonio Cavazos(The University of Texas MD Anderson Cancer Center), Mecit Kaplan(The University of Texas MD Anderson Cancer Center), Katarzyna Tomczak(Postgraduate School of Molecular Medicine), Michael Andreeff(The University of Texas MD Anderson Cancer Center), Sriram S. Shanmugavelandy(AbbVie (United States)), Daniel Herranz(Spanish National Cancer Research Centre), Sujan Piya(The University of Texas MD Anderson Cancer Center), Marcin M. Kamiński(St. Jude Children's Research Hospital), Alessia Lodi(The University of Texas at Austin), Jiyang Yu(Columbia University Irving Medical Center), Eric Davis(The University of Texas MD Anderson Cancer Center), Jason Gay(The University of Texas MD Anderson Cancer Center), Trang Hoang(Université de Montréal), Maria Emilia Di Francesco(The University of Texas MD Anderson Cancer Center), Wentao Yang(American School Health Association), Luciana Melo Garcia(Université Laval)
Cited by 6
Related Papers
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
|Współczesna Onkologia|2015|3.5k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k